Abstract:Cardiovascular disease (CVD) and metabolic syndrome (MetS) depends on sex, age and hormonal status and is worsened by comprised gut barrier function. Previous work establishes that loss of estrogen and age comprises intestinal barrier function permeability exacerbating systemic inflammation, increasing gut oxidative stress, and elevating pro-inflammatory cytokines. We hypothesize that loss of estrogen during menopause underlies sex- and age-dependent pathological remodeling in gut barrier function leading to increased risk for CVD and MetS. C57BL-6 male and female mice were fed a high-fat-diet (HFD, 45% fat); menopause was induced via 21 days of 4-vinylcycohexane diepoxide (VCD) intraperitoneal injections (controls were injected with sesame oil) in adult and aged female mice. Diestrus was reached 14+days after the end of VCD injections and menopause was determined by cytology. Upon sacrifice, plasma was collected, and intestines were flash frozen. LPS assays were performed on plasma samples of premenopausal (n=8), menopausal (n=10), aged menopausal (n=6), and male mice (n=11). Male mice, and aged menopausal mice had significantly higher circulating endotoxin levels than premenopausal mice, while menopausal mice did not significantly differ from pre-menopause. These results indicate that age and sex impact barrier leakiness. Further, these results highlight that barrier integrity in menopause is distinctly different from aged menopause mice.Quantitative proteomics of ileum samples in premenopausal (n=5), menopausal (n=5), aged menopausal (n=5), and male mice (n=5) identified 7664 proteins with >1 unique peptide of which 134 proteins were significant (p<0.05) with a max fold change ˂1.27 across all groups. Protein expression of all groups was assessed using principal component analysis. Aged menopausal mice cluster closer to premenopausal mice than menopausal mice. These results indicate that changes in the ileum during menopause are different than those observed in aging. Compared to premenopausal mice, menopausal mice have significantly increased in proteins involved in the Go-biological processes including an enrichment in proteins involved in the innate immune system (6.3 fold enrichment, FE, -log10p=0.00006), phagocytosis recognition (19.82 FE, -log10p=1.14), defense response to bacterium (10.066 FE, -log10p=9.56), and B cell receptor signaling pathways (20.311 FE, -log10p=9.33). In contrast, male mice compared to premenopausal mice show a significant decrease in proteins involved in phagocytosis recognition (22.57 FE, -log10p=4.28), defense response to bacterium (12.898 FE, -log10p=2.76), and B cell receptor signaling pathway (20.56 FE, -log10p=8.12). These results indicate an increase in immune activity in menopausal female mice and a decrease in male mice compared to premenopausal female mice. In summary, these data demonstrate the change within the gut during menopause is dissimilar to those seen in male and aging mice. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Sexual dimorphism in intestinal absorption and lymphatic transport of dietary lipids

17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice

Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects.

17β-Estradiol inhibits oleic acid-induced rat VSMC Proliferation and migration by restoring PGC-1α expression

17Β-Estrodial INCREASES ABCA1 EXPRESSION AND CHOLESTEROL EFFLUX TO APOA I IN VIVO AND IN VITRO

Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development

Sex Differences in the Formation of Atherosclerosis Lesion in Apoe-/-mice and the Effect of 17Β-Estrodiol on Protein S-nitrosylation.

GW24-e2301 17β-estradiol reduces lipid accumulation in vascular smooth muscle cells through liver X receptor α pathway

β-estradiol adjusts intestinal function via ERβ and GPR30 mediated PI3K/AKT signaling activation to alleviate postmenopausal dyslipidemia

Sexual Dimorphism in Lipid Metabolism and Gut Microbiota in Mice Fed a High-Fat Diet

Role of Estrogens in the Regulation of Liver Lipid Metabolism.

Female sex hormones are necessary for the metabolic effects mediated by loss of Interleukin 18 signaling

17 Beta-Estradiol Promotes Cholesterol Efflux From Vascular Smooth Muscle Cells Through A Liver X Receptor Alpha-Dependent Pathway

Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling

Differential gene expression in liver and small intestine from lactating rats compared to age-matched virgin controls detects increased mRNA of cholesterol biosynthetic genes

Gut microbiota and acylcarnitine connect the beneficial association between estrogen and lipid metabolism disorders in ovariectomized mice

Estrogen Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha Release From Murine Macrophages

Sex, age and menopause differentially impact gut barrier function and proteomic profile

Differences in the Reaction of Hyperlipidemia on Different Endothelial Progenitor Cells Based on Sex.

17Β-Estradiol Suppresses the Macrophage Foam Cell Formation Associated with SOCS3

Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice